Skip to main content
Recall Canary
Aripiprazole 30 mg Tablets
← Back to all recalls
DRUG RECALLMODERATE

Aripiprazole 30 mg Tablets

Ajanta Pharma is recalling Aripiprazole 30 mg tablets due to a mix-up with Voriconazole 50 mg tablets.

What to do

Check your medication bottle immediately to ensure it contains the correct tablets. If you have received Voriconazole instead of Aripiprazole, stop using the product and contact your pharmacist or healthcare provider.

Posted
Updated
Recall No.
D-0594-2026
Agency
Firm
Ajanta Pharma USA Inc
Recall ID
99046
Status
ONGOING

Why it was recalled

Ajanta Pharma is recalling one lot of Aripiprazole 30 mg tablets due to a product mix-up where bottles were found to contain Voriconazole 50 mg tablets instead. Consuming the incorrect medication poses a risk of adverse health effects.

Is mine affected?

Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.

Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-056-03.

Recall #
D-0594-2026

Where it was sold

Distributed nationwide.

Other recent recalls from Ajanta Pharma USA Inc

← Back to all recalls

Editorial summary by Recall Canary · last updated 2026-06-17 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification